Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arterial Vascular Engineering AVEI -- Ignore unavailable to you. Want to Upgrade?

To: GuyNixon who wrote (73)	3/11/1998 10:32:00 AM
From: GuyNixon	Read Replies (1) \| Respond to of 410

Herb Greenberg talks about AVEI in his daily column in The Street. Com. His main points 1. Bear Stern analyst upgraded the stock based on better than expected sales, but... 2. The analyst is skeptical on how AVEI can grow rapidly next year given the entry of competitors (eg. Boston Scientific), sees stent price under pressure in 1999. Hence, AVEI margin as well. 3. Herb question the wisdom on recommending a stock which may end up in trouble 12 months from now. Because investors will have to jump ship at the right time. 4. Herb also point out that AVEI's current valuation is about twice the size of the entire US stent market.